Coronavirus disease 2019 in an orthotopic liver transplant recipient living with human immunodeficiency virus

© 2020 Wiley Periodicals LLC..

Coronavirus disease 2019 (COVID-19), mediated by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can manifest with flu-like illness and severe pneumonia with acute respiratory distress syndrome (ARDS). Immunocompromised patients merit particular attention as altered host immunity may influence both disease severity and duration of viral shedding as is described with several other ribonucleic acid respiratory viruses. Yet immunocompromised status alone, in the absence of other comorbidities, may not necessarily predict severe illness presentations and poorer clinical outcomes as indicated by recent reports of COVID-19-infected solid organ transplant recipients and people living with human immunodeficiency virus (HIV). Such patients may even be spared the robust inflammatory response that precipitates ARDS associated with COVID-19, complicating the management of iatrogenic immunosuppression in this setting. We present a case of an orthotopic liver transplant recipient with well-controlled HIV who successfully recovered from a mild, flu-like illness attributed to SARS-CoV-2.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:22

Enthalten in:

Transplant infectious disease : an official journal of the Transplantation Society - 22(2020), 5 vom: 14. Okt., Seite e13351

Sprache:

Englisch

Beteiligte Personen:

Modi, Anita R [VerfasserIn]
Koval, Christine E [VerfasserIn]
Taege, Alan J [VerfasserIn]
Modaresi Esfeh, Jamak [VerfasserIn]
Eghtesad, Bijan [VerfasserIn]
Narayanan Menon, K V [VerfasserIn]
Quintini, Cristiano [VerfasserIn]
Miller, Charles [VerfasserIn]

Links:

Volltext

Themen:

4QWG6N8QKH
Anti-HIV Agents
COVID-19
Case Reports
HIV
Hydroxychloroquine
Immunocompromised
Immunosuppressive Agents
Journal Article
Orthotopic liver transplantation
Prednisone
Review
VB0R961HZT

Anmerkungen:

Date Completed 15.12.2020

Date Revised 07.12.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1111/tid.13351

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM310802393